These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 1555274)

  • 21. Shock occurrence and survival in 241 patients with implantable cardioverter-defibrillator therapy.
    Grimm W; Flores BT; Marchlinski FE
    Circulation; 1993 Jun; 87(6):1880-8. PubMed ID: 8504500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do patients with an implantable defibrillator live longer?
    Böcker D; Block M; Isbruch F; Wietholt D; Hammel D; Borggrefe M; Breithardt G
    J Am Coll Cardiol; 1993 Jun; 21(7):1638-44. PubMed ID: 8496531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Short-term and long-term outcome of left heart function after cardioverter defibrillator implantation].
    Takeichi K; Kasanuki H; Ohnishi S; Endoh Y; Hosoda S
    J Cardiol; 1996 Nov; 28(5):277-86. PubMed ID: 8953401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of deaths in patients with an implantable cardioverter defibrillator.
    Edel TB; Maloney JD; Moore SL; McAllister H; Gohn D; Shewchik JM; Alexander L; Firstenberg MS; Castle LW; Simmons TW
    Pacing Clin Electrophysiol; 1992 Jan; 15(1):60-70. PubMed ID: 1371002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.
    Klein H; Auricchio A; Reek S; Geller C
    Am J Cardiol; 1999 Mar; 83(5B):91D-97D. PubMed ID: 10089848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term multicenter experience with a second-generation implantable pacemaker-defibrillator in patients with malignant ventricular tachyarrhythmias. The Guardian Multicenter Investigators Group.
    Saksena S; Poczobutt-Johanos M; Castle LW; Fogoros RN; Alpert BL; Kron J; Pacifico A; Griffin J; Ruskin JN; Kehoe RF
    J Am Coll Cardiol; 1992 Mar; 19(3):490-9. PubMed ID: 1537999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome of Cardiac Sarcoidosis Presenting With High-Grade Atrioventricular Block.
    Nordenswan HK; Lehtonen J; Ekström K; Kandolin R; Simonen P; Mäyränpää M; Vihinen T; Miettinen H; Kaikkonen K; Haataja P; Kerola T; Rissanen TT; Kokkonen J; Alatalo A; Pietilä-Effati P; Utriainen S; Kupari M
    Circ Arrhythm Electrophysiol; 2018 Aug; 11(8):e006145. PubMed ID: 30354309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term arrhythmia-free survival in patients with severe left ventricular dysfunction and no inducible ventricular tachycardia after myocardial infarction.
    Zaman S; Narayan A; Thiagalingam A; Sivagangabalan G; Thomas S; Ross DL; Kovoor P
    Circulation; 2014 Feb; 129(8):848-54. PubMed ID: 24381209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
    Bardy GH; Yee R; Jung W
    J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secondary prevention of sudden death: the Dutch Study, the Antiarrhythmics Versus Implantable Defibrillator Trial, the Cardiac Arrest Study Hamburg, and the Canadian Implantable Defibrillator Study.
    Cappato R
    Am J Cardiol; 1999 Mar; 83(5B):68D-73D. PubMed ID: 10089843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preventive effectiveness of implantable cardioverter defibrillator in reducing sudden cardiac death in the Chinese population: a multicenter trial of ICD therapy versus non-ICD therapy.
    Hua W; Niu H; Fan X; Ding L; Xu YZ; Wang J; Chen K; Wang F; Zhang S;
    J Cardiovasc Electrophysiol; 2012 Nov; 23 Suppl 1():S5-9. PubMed ID: 23140347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electrical storm presages nonsudden death: the antiarrhythmics versus implantable defibrillators (AVID) trial.
    Exner DV; Pinski SL; Wyse DG; Renfroe EG; Follmann D; Gold M; Beckman KJ; Coromilas J; Lancaster S; Hallstrom AP;
    Circulation; 2001 Apr; 103(16):2066-71. PubMed ID: 11319196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical experience in patients with implantable cardioverter defibrillators.
    Tsuji H; Shahian DM; Venditti FJ
    Jpn Circ J; 1991 Jul; 55(7):669-75. PubMed ID: 1880899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. When is it safe not to replace an implantable cardioverter defibrillator generator?
    Tchou P; Axtell K; Anderson AJ; Keim S; Sra J; Troup P; Jazayeri M; Avitall B; Akhtar M
    Pacing Clin Electrophysiol; 1991 Nov; 14(11 Pt 2):1875-80. PubMed ID: 1721192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction in defibrillator shocks with an implantable device combining antitachycardia pacing and shock therapy.
    Leitch JW; Gillis AM; Wyse DG; Yee R; Klein GJ; Guiraudon G; Sheldon RS; Duff HJ; Kieser TM; Mitchell LB
    J Am Coll Cardiol; 1991 Jul; 18(1):145-51. PubMed ID: 2050917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does reception of appropriate shocks from the implantable cardioverter defibrillator affect survival?
    Tchou P; Axtell K; Keim S; Anderson AJ; Troup P; Jazayeri M; Avitall B; Akhtar M
    Pacing Clin Electrophysiol; 1991 Nov; 14(11 Pt 2):1929-34. PubMed ID: 1721201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implantable cardioverter defibrillator therapy activation for high risk patients with relatively well preserved left ventricular ejection fraction. Does it really work?
    Gatzoulis KA; Tsiachris D; Dilaveris P; Archontakis S; Arsenos P; Vouliotis A; Sideris S; Trantalis G; Kartsagoulis E; Kallikazaros I; Stefanadis C
    Int J Cardiol; 2013 Aug; 167(4):1360-5. PubMed ID: 22534047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival of patients who have received appropriate shocks from their implantable defibrillators.
    Fogoros RN; Elson JJ; Bonnet CA
    Pacing Clin Electrophysiol; 1991 Nov; 14(11 Pt 2):1842-5. PubMed ID: 1721185
    [No Abstract]   [Full Text] [Related]  

  • 40. Baroreflex sensitivity assessed with the sequence method is associated with ventricular arrhythmias in patients implanted with a defibrillator for the primary prevention of sudden cardiac death.
    Garcia R; Degand B; Fraty M; Le Marcis V; Bidegain N; Laude D; Tavernier M; Le Gal F; Hadjadj S; Saulnier PJ; Ragot S
    Arch Cardiovasc Dis; 2019 Apr; 112(4):270-277. PubMed ID: 30670362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.